Publications by authors named "D M Isaza"

Induced oncoproteins degradation provides an attractive anti-cancer modality. Activation of anaphase-promoting complex (APC/C) prevents cell-cycle entry by targeting crucial mitotic proteins for degradation. Phosphorylation of its co-activator CDH1 modulates the E3 ligase activity, but little is known about its regulation after phosphorylation and how to effectively harness APC/C activity to treat cancer.

View Article and Find Full Text PDF

Background: European Society of Cardiology (ESC) guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation (NSTEMI) recommend Intensive Care Unit (ICU) surveillance during the first 24-48 h. Interestingly, the in-hospital mortality of NSTEMI patients has consistently decreased, giving some patients the option to be managed in general hospital wards. The ACTION ICU score has been proposed to identify high-risk patients with NSTEMI and guide the selective risk-based need for ICU care.

View Article and Find Full Text PDF
Article Synopsis
  • * A case study highlights a 71-year-old man who experienced severe allergic symptoms and chest pain after taking ciprofloxacin, leading to a diagnosis of a life-threatening heart condition caused by this medication.
  • * The report emphasizes the need for doctors to recognize the link between allergic reactions and heart issues for timely diagnosis and appropriate treatment to prevent fatal outcomes.
View Article and Find Full Text PDF

• Takotsubo is a form of transient and reversible regional wall-motion abnormalities. • Biventricular Takotsubo is atypical and has a poorer prognosis. • Pheochromocytomas are rare neuroendocrine tumors of the adrenal glands.

View Article and Find Full Text PDF

Background: Abiraterone is a medication frequently used for metastatic castrate-resistant prostate cancer. We report a case of non-sustained episodes of TdP associated with severe hypokalemia due to androgen-deprivation therapy. Few case presentations describe this association; the novelty lies in the potentially lethal cardiovascular events among cancer patients receiving hormonal therapy.

View Article and Find Full Text PDF